Stressgen (VSE: SSB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Heat Shock who wrote (120)	5/30/2000 7:31:00 PM
From: Heat Shock	Read Replies (1) of 236

To all: looks like StressGen's anal dysplasia/anal cancer immunotherapy will have an unfortunately increasing potential patient base due to the success of anti-AIDS treatment. HIV-Related Anal Cancer Incidence Increased in Long-Term Survivors BETHESDA, May 16 (Reuters Health) - Long-term HIV infection increases the incidence of anal cancer among homosexual men in Australia by 34-fold, according to new data presented Tuesday at the Fourth International AIDS Malignancy Conference at the National Institutes of Health. Whole story: oncology.medscape.com You have to sign on with medscape, but it's free and they are good about no junk mail. Heat

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next